Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia and ulerythema ophryogenes may be related and can evolve from one to the other.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Macrophages are more involved in Lichen planopilaris than in Frontal fibrosing alopecia.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Hair transplant destroyed by lichen planopilaris.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

A genetic marker linked to a type of hair loss was found in most patients studied.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

Frontal Fibrosing Alopecia might be an autoimmune disease.

The mTOR pathway proteins are altered in the hair follicles of patients with Lichen Planopilaris and Frontal Fibrosing Alopecia.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.